REDWOOD CITY, Calif., May 21, 2013/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...
The top stocks to gain during after-market hours on the Nasdaq on Tuesday were FX Energy Inc, NetApp Inc, Canadian Solar Inc, DryShips Inc, and AcelRx Pharmaceuticals Inc. The top after-market losers on the Nasdaq were AMAG Pharmaceuticals Inc, ...
REDWOOD CITY, Calif., May 16, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...
AcelRx Pharmaceuticals (NASDAQ: ACRX) traded up 5.50% on Wednesday, hitting $7.86. AcelRx Pharmaceuticals has a 1-year low of $2.27 and a 1-year high of $6.35.
Boston, MA 05/23/2013 (wallstreetpr) - The share prices of AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) surged by 13.44 percent to close at $7.26 per share for the end of last trading session.
ReneSola Ltd. (ADR) (NYSE:SOL) shares increased 4.86% to $2.59. The company, on May 10, announced it provided modules for use in three community-scale solar power projects in Vermont in the last few months.
REDWOOD CITY, Calif., May 8, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...
REDWOOD CITY, Calif., May 2, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...
REDWOOD CITY, Calif., May 3, 2013 - /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. To see all exchange delays, please see disclaimer.